4 Stocks To Watch: BLUE, CLVS, FMI, KEM – Investing.com

This post was originally published on this site

bluebird bio, Inc. (NASDAQ:) has been on a wonderful run, and although it pulled back on Monday, it snapped right back 2.80, or 2.55%, to 112.60, on 877,261 shares traded on Tuesday. There’s still 12.2 days to cover , and it looks like it may be accelerating. Technicals look good. At one point, about a year and a half ago, .this stock was trading up in the 140.00 zone If it can accelerate beyond the channel, it could get up to 138-42, but there is also the possibility that it could consolidate in this area.

Clovis Oncology Inc (NASDAQ:) is one of our favorites, jumping another 2.90, or 4.8%, to 62.99, on 1.76 million shares traded on Tuesday. It got all the way day to 45.42 in May, and was looking pretty dire. It’s now 18 points higher than that. It recently broke the declining topsline, retested, formed a right-handed extended V, broke out and through the April highs, and is now testing the 64.31. It may get there as early as Wednesday morning. If it gets through that, I’m looking at 71-2. It would be interesting.

Foundation Medicine, Inc. (NASDAQ:) is one of swing trades, that is doing great, popping another 1.35, or 3.4%, to 40.85, on 189,814 shares traded on Tuesday, and continues to push up. It broke out in February, formed a 3-wave, corrective falling wedge, then spiked to 35, pulled back to 30, consolidated, broke out again, holding the 50-day and the trendline, and at the 32 level, it moved up to 43. and pulled back on Monday. If it gets through 43, we’re looking at 50 as the next target.

KEME T Corporation (NYSE:) recovered dramatically on Tuesday after a 2-day sharp drop took it right down to support. It spiked up 57 cents, or 4.3%, to 13.89, on 1.5 million shares traded. The jury is still out on this one, but the volume is good, and it still needs to get to 14.85. Beyond that, I’m looking at 17 1/2 going forward.

On the long side, stocks included bluebird bio, Inc. (NASDAQ:), Clovis Oncology Inc (CLVS), Foundation Medicine, Inc. (FMI), Hortonworks, Inc. (NASDAQ:), Hydrogenics Corporation (NASDAQ:), ImmunoGen, Inc. (NASDAQ:), KEMET Corporation (KEM), Kite Pharma, Inc. (NASDAQ:), Direxion Daily S&P Biotech Bull 3X ETF (NYSE:), Lennar Corporation (NYSE:), Melco Resorts & Entertainment L (NASDAQ:), NantKwest (NASDAQ:), Omeros Corporation (NASDAQ:), ORBCOMM Inc. (NASDAQ:), Sangamo Therapeutics, Inc. (NASDAQ:), Scientific Games Corporation (NASDAQ:), Sierra Wireless, Inc. (NASDAQ:), Teladoc, Inc. (NYSE:), Triton International Ltd (NYSE:), Triton International Ltd (NYSE:), Tesla Motors, Inc. (NASDAQ:), and XPO Logistics, Inc. (NYSE:).